Leading biotech firms including MBX and uniQure have recently secured nine-figure funding rounds, reflecting robust investor confidence. Mission BioCapital announced a $134 million raise for its sixth investment fund targeting early-stage companies specializing in cutting-edge life sciences innovation. These financings underscore expanding capital flows into biopharma development and the sector’s growth prospects.